InvestorsHub Logo
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Wednesday, 01/08/2020 1:40:26 PM

Wednesday, January 08, 2020 1:40:26 PM

Post# of 8022
BARDA order was discussed on the MDWD Q3 earnings, here is the important parts on the last page of Q&A

https://seekingalpha.com/article/4306787-mediwound-ltd-mdwd-ceo-sharon-malka-on-q3-2019-results-earnings-call-transcript?page=5


Regardless this clinical supply for the NEXT, BARDA is committed to procure $16.5 million of NexoBrid for stockpiling which we believe, based on discussion that we have with BARDA, that they can or will trigger throughout the end of this year, enable us to start recognizing revenues upon deliveries from the first quarter of next year.

....

Sharon Malka

So, BARDA - the rate work at BARDA will provide us with a purchase order for all the 16,000 units which is a 16.5 million unit. In terms of revenue recognitions in our financial, it will be based on deliveries of actual products to BARDA’s warehouses in the U.S.

And in accordance with the delivery schedule, I agree with BARDA which is based on our capacity and manufacturing plan. It will be recognized upon six quarter starting from the quarter after we trigger this procurement, and will be recognized throughout those - this period.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCEL News